Researchers increasingly are interested in reaching the small airways with fine-particle inhaled corticosteroids to help reduce inflammation associated with asthma and chronic obstructive pulmonary disease. But the question over whether these drugs are better than larger-particle aerosols remains unanswered. Objectives for the web presentation are to:
- Review pathology of small airways disease
- Discuss measurement of small airways’ function
- Contrast relevance of small airways’ function in asthma and COPD
- Explore therapeutic options in the treatment of small airways disease
SPEAKER: Alphonso Quinones, DHA(C), MA, FACHE, RRT-NPS, RPSGT, RPFT, CCT, AE-C, director of respiratory therapy, North Shore University Hospital, Manhasset, NY
DATE: Wednesday, Jan. 25, 1-2 EST
WHERE: Your computer screen
MORE ABOUT THE PRESENTER:
Alphonso Quinones is also president of Quinones Healthcare Seminars, LLC. He is assistant professor at Molloy College, Rockville Centre, NY. He is chairman for the NYS Respiratory Therapy Licensure Board. He has published approximately 30 original research abstracts and review articles related to respiratory therapy and critical care.
Aiming for Asthma Relief
Discover five studies leading the way to effective new therapies.
Focus on Small Airways
Learn how targeted treatment may improve disease management and patient outcomes.
Changing Asthma Management
Read how eNO can help identify difficult-to-control asthma patients with greater allergic inflammation and airflow reactivity, including those most likely to seek emergency care.
Looking for more online educational opportunities?
See what’s next on our webinar schedule.